Pharmacokinetics and Bioequivalence of Abiraterone Acetate Tablets in Healthy Chinese Volunteers: An Open, Randomized, Single-Dose, Three-Period, Three-Sequence Crossover Study

BACKGROUND AND OBJECTIVE: Abiraterone acetate tablet is an inhibitor of androgen synthesis, primarily for the treatment of metastatic castration-resistant prostate cancer (mCRPC). This study evaluated the bioequivalence and pharmacokinetics of the reference and test formulations of abiraterone aceta...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Zhao-xin, Wang, Chen-jing, Shi, Ping, Liu, Yan-ping, Li, Ting, Sun, Fei-fei, Fu, Yao, Gao, Xiao-meng, Ma, Ya-ping, Cao, Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10293147/
https://www.ncbi.nlm.nih.gov/pubmed/37012461
http://dx.doi.org/10.1007/s40268-023-00418-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10293147/
https://www.ncbi.nlm.nih.gov/pubmed/37012461
http://dx.doi.org/10.1007/s40268-023-00418-6

Ejemplares similares